PharmaLex Denmark A/S — Credit Rating and Financial Key Figures
CVR number: 18652439
Agern Alle 24, 2970 Hørsholm
invoice@jacobsenadvice.com
tel: 74441936
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 21 537.26 | 22 717.79 | 29 956.91 | 20 585.54 | 26 015.26 |
| Employee benefit expenses | -15 857.26 | -19 353.66 | -22 472.89 | -18 911.37 | -23 656.74 |
| Total depreciation | -95.35 | - 112.40 | -91.28 | -68.46 | - 107.50 |
| EBIT | 5 584.65 | 3 251.74 | 7 392.74 | 1 605.71 | 2 251.02 |
| Other financial income | 205.03 | 19.84 | 27.08 | 20.48 | |
| Other financial expenses | -75.53 | -80.16 | - 107.13 | -37.72 | -36.98 |
| Pre-tax profit | 5 509.12 | 3 376.61 | 7 305.45 | 1 595.08 | 2 234.53 |
| Income taxes | -1 242.65 | - 742.94 | -1 524.97 | - 350.92 | - 488.78 |
| Net earnings | 4 266.47 | 2 633.66 | 5 780.48 | 1 244.16 | 1 745.75 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 196.07 | 144.40 | 190.87 | 221.41 | 170.21 |
| Tangible assets total | 196.07 | 144.40 | 190.87 | 221.41 | 170.21 |
| Other receivables | 368.81 | 378.02 | 387.84 | 427.82 | 438.52 |
| Investments total | 368.81 | 378.02 | 387.84 | 427.82 | 438.52 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 3 346.51 | 4 562.36 | 4 342.97 | 4 170.56 | 4 564.31 |
| Current amounts owed by group member comp. | 7 045.59 | 5 049.73 | 961.88 | 1 286.89 | 26.77 |
| Prepayments and accrued income | 13.39 | 17.18 | 12.83 | 16.42 | 14.43 |
| Current other receivables | 50.30 | 40.13 | 45.01 | 593.17 | |
| Current deferred tax assets | 62.81 | 161.69 | 46.63 | 32.88 | 148.80 |
| Short term receivables total | 10 518.59 | 9 831.10 | 5 409.33 | 5 506.75 | 5 347.48 |
| Cash and bank deposits | 3 234.90 | 955.33 | 6 908.14 | 6 969.24 | 6 587.06 |
| Cash and cash equivalents | 3 234.90 | 955.33 | 6 908.14 | 6 969.24 | 6 587.06 |
| Balance sheet total (assets) | 14 318.37 | 11 308.85 | 12 896.18 | 13 125.22 | 12 543.27 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 550.00 | 550.00 | 550.00 | 550.00 | 550.00 |
| Shares repurchased | 5 000.00 | 3 050.00 | 2 600.00 | 1 000.00 | 1 500.00 |
| Retained earnings | -3 597.18 | -2 380.71 | -2 347.05 | 2 433.43 | 2 177.59 |
| Profit of the financial year | 4 266.47 | 2 633.66 | 5 780.48 | 1 244.16 | 1 745.75 |
| Shareholders equity total | 6 219.29 | 3 852.95 | 6 583.43 | 5 227.59 | 5 973.34 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 6.35 | 240.31 | 60.81 | 57.31 | 23.35 |
| Advances received | 564.58 | ||||
| Current trade creditors | 293.94 | 253.97 | 146.41 | 247.62 | 241.65 |
| Current owed to group member | 1 512.42 | 359.17 | 855.11 | 1 102.17 | 1 666.38 |
| Short-term deferred tax liabilities | 1 199.13 | 841.83 | 1 494.40 | 1 831.56 | 938.02 |
| Other non-interest bearing current liabilities | 5 087.24 | 5 760.63 | 3 191.44 | 4 336.66 | 3 700.53 |
| Accruals and deferred income | 322.30 | ||||
| Current liabilities total | 8 099.08 | 7 455.90 | 6 312.75 | 7 897.63 | 6 569.94 |
| Balance sheet total (liabilities) | 14 318.37 | 11 308.85 | 12 896.18 | 13 125.22 | 12 543.27 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.